Posts by: Iqra Mumal

News

While a significant proportion of non-Hodgkin’s lymphoma survivors suffer from severe fatigue, the type of initial treatment and Rituxan (rituxumab) use did not influence this outcome, a new study ... Read more

April 5, 2019

Three-tiered Combination Stimulates Immune System to Attack Lymphoma Cells, Phase 1/2 Trial Shows

News

A combination of oral Imbruvica (ibrutinib), intratumoral CpG, and local low-dose radiation stimulates the immune system to safely and effectively attack lymphoma cells, according to a new study. The ... Read more

August 3, 2018

Gazyva Infusion Could Be Shorter for Some NHL Patients, Study Finds

News

Shortening the time needed for an infusion of Gazyva (obinutuzumab) did not affect the safety of Japanese patients with previously untreated CD20-positive B-cell non-Hodgkin’s lymphoma, a new study shows. “Safety, ... Read more

August 1, 2018

Ranimustine-based Conditioning Regimen Before Stem Cell Transplant Effective in DLBCL Patients, Study Suggests

News

A chemotherapeutic regimen that includes high-dose ranimustine may be used to prepare patients for a stem cell transplant, ultimately leading to high survival rates in patients with relapsed or ... Read more

June 29, 2018

New Biosensor Sheds Light on Behavior of Individual Cancer Cells, Study Reports

News

A newly developed biosensor that harnesses the power of nanophotonics is able to detect the secretion of cytokines — small inflammatory molecules that play important roles in cancer — ... Read more

May 11, 2018

Bowel Rest Not Seen to Benefit NHL Patients with Gastrointestinal Involvement in Study

News

Bowel rest — in which patients do not ingest any food and are fed intravenously — does not significantly lower perforation rates or improve overall outcomes in non-Hodgkin’s lymphoma patients ... Read more

April 20, 2018

Patients with Peripheral T-cell Lymphoma Resistant to First-Line Therapy Show Worse Outcomes, Study Finds

News

Patients with peripheral T-cell lymphomas receiving standard treatment have worse outcomes if they are not responsive to first-line therapy, a prospective study shows. Bone marrow transplants undertaken after these therapies ... Read more

March 29, 2018March 29, 2018

CAR T-cell Therapies Deemed Cost-effective for B-cell Cancers in New Report

News

Treatment with chimeric antigen receptor (CAR) T-cell therapies in B-cell cancers, like certain types of lymphoma and leukemia, is associated with an increase in quality-adjusted and overall survival compared ... Read more

March 15, 2018

Stem Cell Transplants Bring Long-term Benefits to Relapsed Follicular Lymphoma Patients

News

Results from a recent large-scale study indicate that stem cell transplants should be considered for the treatment of patients with relapsed follicular lymphoma. The study, “Allogeneic Hematopoietic Stem Cell ... Read more

March 5, 2018March 5, 2018

Stem Cell Transplants Can Benefit Lymphoma Patients Who Fail to Respond to Chemo, Study Shows

News

Stem cell transplants can lead to excellent outcomes in certain B-cell lymphoma patients who failed to respond to chemoimmunotherapy, a study shows. The results apply to patients with primary mediastinal B-cell ... Read more

Posts by: Iqra Mumal

Iqra Mumal

Age, Obesity, Comorbidities Linked with Severe Fatigue Among Non-Hodgkin’s Lymphoma Survivors

Three-tiered Combination Stimulates Immune System to Attack Lymphoma Cells, Phase 1/2 Trial Shows

Ranimustine-based Conditioning Regimen Before Stem Cell Transplant Effective in DLBCL Patients, Study Suggests

New Biosensor Sheds Light on Behavior of Individual Cancer Cells, Study Reports

Bowel Rest Not Seen to Benefit NHL Patients with Gastrointestinal Involvement in Study

Patients with Peripheral T-cell Lymphoma Resistant to First-Line Therapy Show Worse Outcomes, Study Finds

CAR T-cell Therapies Deemed Cost-effective for B-cell Cancers in New Report

Stem Cell Transplants Bring Long-term Benefits to Relapsed Follicular Lymphoma Patients

Stem Cell Transplants Can Benefit Lymphoma Patients Who Fail to Respond to Chemo, Study Shows

Pin It on Pinterest